Why the study?
Systemic inflammation contributes to LV dysfunction, but the role of the NLRP3 inflammasome in LV dysfunction during acute inflammatory conditions remains unclear.
Acute LPS-induced cardiac dysfunction and structural changes are partially mediated by the NLRP3 inflammasome and pyroptotic pathways.
No takes yet. Share an insight, caveat, or question.
NLRP3 antagonism may mitigate LPS cardiomyopathy in models; hypothesis-generating for human sepsis trials, should not change practice.
Maluleke et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: